JP2020511528A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020511528A5 JP2020511528A5 JP2019568591A JP2019568591A JP2020511528A5 JP 2020511528 A5 JP2020511528 A5 JP 2020511528A5 JP 2019568591 A JP2019568591 A JP 2019568591A JP 2019568591 A JP2019568591 A JP 2019568591A JP 2020511528 A5 JP2020511528 A5 JP 2020511528A5
- Authority
- JP
- Japan
- Prior art keywords
- stimulus
- composition
- sre
- car
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024182138A JP2025013868A (ja) | 2017-03-03 | 2024-10-17 | 免疫療法のための組成物及び方法 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762466601P | 2017-03-03 | 2017-03-03 | |
| US62/466,601 | 2017-03-03 | ||
| US201762484063P | 2017-04-11 | 2017-04-11 | |
| US62/484,063 | 2017-04-11 | ||
| US201762542402P | 2017-08-08 | 2017-08-08 | |
| US62/542,402 | 2017-08-08 | ||
| PCT/US2018/020704 WO2018160993A1 (en) | 2017-03-03 | 2018-03-02 | Compositions and methods for immunotherapy |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021032321A Division JP2021088598A (ja) | 2017-03-03 | 2021-03-02 | 免疫療法のための組成物及び方法 |
| JP2024182138A Division JP2025013868A (ja) | 2017-03-03 | 2024-10-17 | 免疫療法のための組成物及び方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020511528A JP2020511528A (ja) | 2020-04-16 |
| JP2020511528A5 true JP2020511528A5 (enExample) | 2021-04-15 |
| JP7660343B2 JP7660343B2 (ja) | 2025-04-11 |
Family
ID=63370245
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019568591A Active JP7660343B2 (ja) | 2017-03-03 | 2018-03-02 | 免疫療法のための組成物及び方法 |
| JP2021032321A Pending JP2021088598A (ja) | 2017-03-03 | 2021-03-02 | 免疫療法のための組成物及び方法 |
| JP2024182138A Pending JP2025013868A (ja) | 2017-03-03 | 2024-10-17 | 免疫療法のための組成物及び方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021032321A Pending JP2021088598A (ja) | 2017-03-03 | 2021-03-02 | 免疫療法のための組成物及び方法 |
| JP2024182138A Pending JP2025013868A (ja) | 2017-03-03 | 2024-10-17 | 免疫療法のための組成物及び方法 |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP3589373A4 (enExample) |
| JP (3) | JP7660343B2 (enExample) |
| CN (1) | CN110913954A (enExample) |
| AU (1) | AU2018226857B2 (enExample) |
| CA (1) | CA3055200A1 (enExample) |
| WO (1) | WO2018160993A1 (enExample) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10704021B2 (en) | 2012-03-15 | 2020-07-07 | Flodesign Sonics, Inc. | Acoustic perfusion devices |
| CA2935960C (en) | 2014-01-08 | 2023-01-10 | Bart Lipkens | Acoustophoresis device with dual acoustophoretic chamber |
| US11377651B2 (en) | 2016-10-19 | 2022-07-05 | Flodesign Sonics, Inc. | Cell therapy processes utilizing acoustophoresis |
| US11708572B2 (en) | 2015-04-29 | 2023-07-25 | Flodesign Sonics, Inc. | Acoustic cell separation techniques and processes |
| US11214789B2 (en) | 2016-05-03 | 2022-01-04 | Flodesign Sonics, Inc. | Concentration and washing of particles with acoustics |
| SG10202111394XA (en) | 2017-04-13 | 2021-12-30 | Senti Biosciences Inc | Combinatorial cancer immunotherapy |
| MA49403A (fr) | 2017-06-12 | 2021-03-24 | Obsidian Therapeutics Inc | Compositions de pde5 et méthodes d'immunothérapie |
| WO2018237323A1 (en) * | 2017-06-23 | 2018-12-27 | The Board Of Trustees Of The Leland Stanford Junior University | Pde5a destabilizing domains |
| KR20220066413A (ko) | 2017-12-14 | 2022-05-24 | 프로디자인 소닉스, 인크. | 음향 트랜스듀서 구동기 및 제어기 |
| JP7520818B2 (ja) * | 2018-09-13 | 2024-07-23 | ンカルタ・インコーポレイテッド | 腫瘍を治療するためのナチュラルキラー細胞組成物および免疫療法の方法 |
| WO2020069005A1 (en) * | 2018-09-28 | 2020-04-02 | Harrow Health, Inc. | Pharmaceutical compositions for prevention or treatment of cytokine release syndrome |
| US11419898B2 (en) | 2018-10-17 | 2022-08-23 | Senti Biosciences, Inc. | Combinatorial cancer immunotherapy |
| AU2019359890B2 (en) | 2018-10-17 | 2024-10-24 | Senti Biosciences, Inc. | Combinatorial cancer immunotherapy |
| CA3114707A1 (en) * | 2018-10-19 | 2020-04-23 | Regents Of The University Of Minnesota | Nk engager molecules and methods of use thereof |
| EP3893901A4 (en) * | 2018-12-11 | 2023-01-04 | The Regents of the University of California | COMPOSITIONS AND METHODS FOR IMMUNOTHERAPIES |
| CN109735558B (zh) * | 2018-12-12 | 2022-04-15 | 中南大学 | 一种重组car19-il24基因、慢病毒载体、car19-il24-t细胞及应用 |
| EP3927728A2 (en) | 2019-02-21 | 2021-12-29 | Xencor, Inc. | Untargeted and targeted il-10 fc-fusion proteins |
| EP3773918A4 (en) | 2019-03-05 | 2022-01-05 | Nkarta, Inc. | ANTI-CD19 CHEMERIC ANTIGEN RECEPTORS AND THEIR USE IN IMMUNOTHERAPY |
| KR20210149251A (ko) * | 2019-03-08 | 2021-12-08 | 옵시디안 테라퓨틱스, 인크. | 조율가능한 조절을 위한 인간 탄산 무수화효소 2 조성물 및 방법 |
| CA3132817A1 (en) | 2019-03-08 | 2020-09-17 | Obsidian Therapeutics, Inc. | Cd40l compositions and methods for tunable regulation |
| JP2022526671A (ja) * | 2019-04-11 | 2022-05-25 | エンクリアー セラピーズ， インク． | 脳脊髄液の改善の方法ならびにそのためのデバイスおよびシステム |
| US20220378824A1 (en) * | 2019-04-30 | 2022-12-01 | Myeloid Therapeutics, Inc. | Engineered chimeric fusion protein compositions and methods of use thereof |
| EP3983538A1 (en) * | 2019-06-12 | 2022-04-20 | Obsidian Therapeutics, Inc. | Ca2 compositions and methods for tunable regulation |
| EP3987028A4 (en) * | 2019-06-21 | 2023-07-19 | Kernal Biologics, Inc. | MODIFIED ONCOSELECTIVE PROTEIN EXPRESSION |
| US20230092895A1 (en) | 2019-08-30 | 2023-03-23 | Obsidian Therapeutics, Inc. | Tandem cd19 car-based compositions and methods for immunotherapy |
| WO2021050789A1 (en) | 2019-09-10 | 2021-03-18 | Obsidian Therapeutics, Inc. | Ca2-il15 fusion proteins for tunable regulation |
| CN114599676A (zh) * | 2019-10-24 | 2022-06-07 | 诺华康制药股份公司 | 新型抗-Nogo-A抗体 |
| WO2021202581A1 (en) * | 2020-03-30 | 2021-10-07 | WUGEN, Inc. | Engineered immune cells for adoptive cell therapy |
| PE20221759A1 (es) * | 2020-03-31 | 2022-11-11 | Hanmi Pharm Ind Co Ltd | Nuevos analogos de il-2 inmunoestimuladores |
| US20230287081A1 (en) * | 2020-04-16 | 2023-09-14 | Nantong Yichen Biopharma. Co. Ltd. | PD-1 mutant polypeptide and preparation and application thereof |
| WO2022060806A1 (en) * | 2020-09-16 | 2022-03-24 | Obsidian Therapeutics, Inc. | Compositions and methods for expression of anti-bcma chimeric antigen receptors with small molecule-regulated il15 in t cells |
| WO2022072558A1 (en) | 2020-09-29 | 2022-04-07 | Enclear Therapies, Inc. | Subarachnoid fluid management method and system |
| US12012441B2 (en) | 2020-10-26 | 2024-06-18 | Neptune Biosciences Llc | Engineered human IL-21 cytokines and methods for using the same |
| CN112225807B (zh) * | 2020-10-30 | 2021-09-07 | 上海洛启生物医药技术有限公司 | 抗il5纳米抗体及其应用 |
| CN117642173A (zh) * | 2020-12-07 | 2024-03-01 | 华东理工大学 | 用于诱导对基因递送靶媒剂的免疫耐受性的方法和试剂盒 |
| AU2021401934A1 (en) * | 2020-12-14 | 2023-06-22 | Allogene Therapeutics, Inc. | Methods and reagents for characterizing car t cells for therapies |
| CN114685683B (zh) * | 2020-12-31 | 2025-07-08 | 博生吉医药科技(苏州)有限公司 | 靶向gd2的car-t细胞及其制备和应用 |
| CN112795543B (zh) * | 2021-02-04 | 2022-09-27 | 华中农业大学 | 杂交瘤细胞株及其分泌的抗草鱼IL-15Rα单克隆抗体和应用 |
| CN116406426A (zh) * | 2021-04-29 | 2023-07-07 | 苏州沙砾生物科技有限公司 | 一种修饰的肿瘤浸润淋巴细胞及其用途 |
| IL310386A (en) * | 2021-07-28 | 2024-03-01 | Prescient Therapeutics Ltd | Universal receptor immune cell therapy |
| CN116082515A (zh) * | 2021-11-08 | 2023-05-09 | 浙江海隆生物科技有限公司 | 一种在大肠杆菌中可溶性表达的口蹄疫病毒衣壳融合蛋白及其制备方法 |
| CN114317385B (zh) * | 2021-11-11 | 2024-02-13 | 元本(珠海横琴)生物科技有限公司 | 一种促进her2亲和体蛋白分泌表达的发酵培养基及发酵工艺 |
| EP4620978A1 (en) * | 2022-11-04 | 2025-09-24 | T-Maximum Pharmaceutical (Suzhou) Co., Ltd. | Universal car-t cell targeting b7h3, and preparation method therefor and use thereof |
| CN115558641B (zh) * | 2022-11-14 | 2023-05-12 | 四川新生命干细胞科技股份有限公司 | 高纯度效应免疫细胞群及其培养方法、试剂组合物和应用 |
| CN115645515A (zh) * | 2022-12-28 | 2023-01-31 | 北京圣美细胞生命科学工程研究院有限公司 | 肿瘤治疗组合物及应用、药物组合物和细胞生长抑制方法 |
| CN120712345A (zh) * | 2022-12-30 | 2025-09-26 | 上药生物治疗（香港）有限公司 | 表达趋化因子受体的细胞及其用途 |
| US20250032612A1 (en) * | 2023-03-10 | 2025-01-30 | The Regents Of The University Of Colorado, A Body Corporate | Anti-cd276 and anti-cd99 logic gated chimeric antigen receptors for the treatment of cancer |
| KR20250164239A (ko) | 2023-03-15 | 2025-11-24 | 교토후고리츠다이가쿠호진 | 펩티드 발현 구축물 및 그의 용도 |
| WO2025160432A1 (en) * | 2024-01-26 | 2025-07-31 | Poseida Therapeutics, Inc. | Methods and compositions for enhancing in vivo persistence and potency of cell therapy |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7198917B2 (en) * | 1997-11-21 | 2007-04-03 | Genentech, Inc. | Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens |
| CN101355928B (zh) * | 2005-04-26 | 2013-05-22 | 卫材R&D管理株式会社 | 用于癌症免疫疗法的组合物和方法 |
| CA2638865A1 (en) * | 2006-02-13 | 2007-10-18 | Genentech, Inc. | Methods and compositions for targeting relt |
| US8173792B2 (en) * | 2007-02-09 | 2012-05-08 | The Board Of Trustees Of The Leland Stanford Junior University | Method for regulating protein function in cells using synthetic small molecules |
| US8530636B2 (en) * | 2008-05-07 | 2013-09-10 | The Board Of Trustees Of The Leland Stanford Junior University | Method for regulating protein function in cells in vivo using synthetic small molecules |
| WO2011146568A1 (en) * | 2010-05-19 | 2011-11-24 | Genentech, Inc. | Predicting response to a her inhibitor |
| MX370348B (es) * | 2013-07-19 | 2019-12-10 | Vib Vzw | Miembros de la familia il-1 modificados dirigidos. |
| WO2017180587A2 (en) * | 2016-04-11 | 2017-10-19 | Obsidian Therapeutics, Inc. | Regulated biocircuit systems |
-
2018
- 2018-03-02 JP JP2019568591A patent/JP7660343B2/ja active Active
- 2018-03-02 AU AU2018226857A patent/AU2018226857B2/en active Active
- 2018-03-02 EP EP18761512.5A patent/EP3589373A4/en active Pending
- 2018-03-02 CA CA3055200A patent/CA3055200A1/en active Pending
- 2018-03-02 WO PCT/US2018/020704 patent/WO2018160993A1/en not_active Ceased
- 2018-03-02 CN CN201880029032.0A patent/CN110913954A/zh active Pending
-
2021
- 2021-03-02 JP JP2021032321A patent/JP2021088598A/ja active Pending
-
2024
- 2024-10-17 JP JP2024182138A patent/JP2025013868A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020511528A5 (enExample) | ||
| JP7627399B2 (ja) | ＴＧＦβシグナルコンバーター | |
| JP7737740B2 (ja) | 抗ｇｐｃ３一本鎖抗体を含むｃａｒ | |
| CN111247242B (zh) | 嵌合抗原受体(CARs)、组合物及其使用方法 | |
| AU2019299439C1 (en) | Chimeric receptors in combination with trans metabolism molecules enhancing glucose import and therapeutic uses thereof | |
| US20200405811A1 (en) | Cd5 chimeric antigen receptor for adoptive t cell therapy | |
| JP7198670B2 (ja) | 免疫調整性ｉｌ２ｒ融合タンパク質およびその使用 | |
| RU2716716C2 (ru) | Композиции и способы для бустинга эффективности адоптивной клеточной иммунотерапии | |
| JP7696658B2 (ja) | ヒトメソセリンを特異的に認識する細胞表面分子、ｉｌ－７、及びｃｃｌ１９を発現する免疫担当細胞 | |
| KR20230129983A (ko) | 조작된 세포 요법을 위한 표적화된 사이토카인 구축물 | |
| CN110520524A (zh) | 靶向肿瘤微环境的嵌合抗原受体t细胞 | |
| CN110352068A (zh) | 合成的免疫受体及其使用方法 | |
| WO2017190100A1 (en) | Nucleic acid constructs for co-expression of chimeric antigen receptor and transcription factor, cells containing and therapeutic use thereof | |
| JP2023168545A (ja) | 二量体抗原受容体（ｄａｒ） | |
| CN115485289A (zh) | 使用工程化的病毒颗粒进行基因递送的方法和组合物 | |
| CN107936120B (zh) | Cd19靶向性的嵌合抗原受体及其制法和应用 | |
| TW202020146A (zh) | 含nef之t細胞及其產生方法 | |
| US20210261646A1 (en) | Chimeric receptors in combination with trans metabolism molecules enhancing glucose import and therapeutic uses thereof | |
| TW201726149A (zh) | 用於免疫療法之組合方法 | |
| US20240368246A1 (en) | Multimeric t-cell modulatory polypeptides and methods of use thereof | |
| CN113728095A (zh) | 工程化的细胞及其用途 | |
| US20220133792A1 (en) | Signaling platforms for chimeric antigen receptor t cells | |
| WO2021233317A1 (en) | Il-12 armored immune cell therapy and uses thereof | |
| CN109456942A (zh) | 通用型嵌合抗原受体t细胞制备技术 | |
| KR20230010228A (ko) | 자연 살해 세포를 표적으로 하는 키메라 항원 수용체 (cars) |